These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2477194)
1. Comparison of failure rates of orthotopic corneal grafts using three different grafting procedures. Moticka EJ; She SC Curr Eye Res; 1989 Aug; 8(8):813-20. PubMed ID: 2477194 [TBL] [Abstract][Full Text] [Related]
2. An improved method of intralamellar keratoplasty in rats. Peterson RJ; Kwedar SA; Moticka EJ Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):281-6. PubMed ID: 8591909 [TBL] [Abstract][Full Text] [Related]
3. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice. Osawa H; Maruyama K; Streilein JW Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of rejection of orthotopic corneal allografts in the rat. Callanan D; Peeler J; Niederkorn JY Transplantation; 1988 Feb; 45(2):437-43. PubMed ID: 3278439 [TBL] [Abstract][Full Text] [Related]
5. The extent of immunological privilege of orthotopic corneal grafts in the inbred rat. Katami M; Madden PW; White DJ; Watson PG; Kamada N Transplantation; 1989 Sep; 48(3):371-6. PubMed ID: 2675395 [TBL] [Abstract][Full Text] [Related]
6. A murine model of interlamellar corneal transplantation. Lau CH; Nicholls SM; Easty DL Br J Ophthalmol; 1998 Mar; 82(3):294-9. PubMed ID: 9602628 [TBL] [Abstract][Full Text] [Related]
7. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply. Sonoda Y; Streilein JW Transplantation; 1992 Oct; 54(4):694-704. PubMed ID: 1412761 [TBL] [Abstract][Full Text] [Related]
8. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients. Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of rejected orthotopic corneal grafts in the rat. Callanan DG; Luckenbach MW; Fischer BJ; Peeler JS; Niederkorn JY Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):413-24. PubMed ID: 2647659 [TBL] [Abstract][Full Text] [Related]
11. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Hori J; Joyce NC; Streilein JW Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061 [TBL] [Abstract][Full Text] [Related]
12. Host-derived endothelial regeneration of corneal transplants in a rat keratoplasty model. Bredow L; Schwartzkopff J; Reinhard T Ophthalmic Res; 2014; 52(2):60-4. PubMed ID: 24993185 [TBL] [Abstract][Full Text] [Related]
14. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):658-64. PubMed ID: 12556396 [TBL] [Abstract][Full Text] [Related]
15. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533 [TBL] [Abstract][Full Text] [Related]